|
Nagy Z, Esiri M M, Jobst K A. Relative roles of plaques and tangles in the dementia of Alzheimer's disease:correlations using three sets of neuropathological criteria [J]. Dementia, 1995(1):21.
|
|
Xu Y F, Zhang Y J, Zhang A H. Attenuation of okadaic acid-induced hyperphosphorylation of cytoskeletal proteins by heat preconditioning and its possible underlying mechanisms [J]. Cell Stress and Chaperones, 2004(3):304.doi: 10.1379/CSC-23R1.1.
|
|
Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy:experimental and clinical evidence of their pleiotropic fects [J]. Pharmacology & Therapeutics, 2007(2):378.doi: 10.1016/j.pharmthera.2006.09.003.
|
|
Zipp F, Waiczies S, Aktas O. Impact of HMG-CoA reductase inhibition on brain pathology [J]. Trends in Pharmacological Sciences, 2007(7):342.doi: 10.1016/j.tips.2007.05.001.
|
|
Fassbender K, Simons M, Bergmann C. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo [J]. Proceedings of the National Academy of Sciences(USA), 2001, (10):5856.doi: 10.1073/pnas.081620098.
|
|
Li L, Cao D, Kim H. Simvastatin enhances learning and memory independent of amyloid load in mice [J]. Annals of Neurology, 2006(6):729.doi: 10.1002/ana.21053.
|
|
马涛, 凌树才, 倪衡建. 一氧化氮对体外培养的胚鼠脑干5-羟色胺能神经元生长发育的影响 [J]. 神经解剖学杂志, 2006(3):323.doi: 10.3969/j.issn.1000-7547.2006.03.014.
|
|
Zhang X, Li F, Bulloj A. Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules [J]. Federation of America Societies for Experimental Biology Journal, 2006(8):1272.
|
|
Gong C X, Liu F, Grundke-Iqbal I. Dysregulation of protein phosphorylation/ dephosphorylation in Alzheimer's disease:a therapeutic target [J]. Journal of Biomedicine and Biotechnology, 2006(3):31825.
|
|
Liu F, Li B, Tung E J. Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation [J]. European Journal of Neuroscience, 2007, (12):3429.doi: 10.1111/j.1460-9568.2007.05955.x.
|
|
Liu F, Grundke-Iqbal I, Iqbal, K. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation [J]. European Journal of Neuroscience, 2005, (8):1942.doi: 10.1111/j.1460-9568.2005.04391.x.
|
|
Kins S, Crameri A, Evans D R. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice [J]. Journal of Biological Chemistry, 2001.38193.
|
|
Sun L, Liu S Y, Zhou X W. Inhibition of protein phosphatase 2A-and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats [J]. Neuroscience, 2003, (4):1175.doi: 10.1016/S0306-4522(02)00697-8.
|
|
Tanimukai H, Grundke-Iqbal I, Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease [J]. American Journal of Pathology, 2005.1761.
|
|
Gong C X, Wang J Z, Iqbal K. Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices [J]. Neuroscience Letters, 2003(2):107.doi: 10.1016/S0304-3940(03)00096-X.
|
|
Salins P, Shawesh S, He Y. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling [J]. Neuroscience Letters, 2007(3):211.doi: 10.1016/j.neulet.2006.07.045.
|
下载:
苏公网安备 32100302010246号
